EUVIMEDEUVIMED entdecken
Vergleichsstudie

Comparison of Referral Rates and Costs Using Fibrosis-4 and Enhanced Liver Fibrosis (ELF) Testing Strategies for Initial Evaluation of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in a Veteran Population

Samrat Yeramaneni, Stephanie T Chang, Ramsey C Cheung, Donald B Chalfin, Kinpritma Sangha, H Roma Levy, Artem T Boltyenkov iD

The Journal of Applied Laboratory Medicine · 02.05.2025 · 10 (3) · 593-604

DOI: 10.1093/jalm/jfae154 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift The Journal of Applied Laboratory Medicine, online erschienen am 15.01.2025. Verfasst von Samrat Yeramaneni und 6 weiteren Autor:innen. Beteiligte Einrichtung: Medical Affairs, Siemens Healthcare Diagnostics Inc., Tarrytown, NY, United States. Hauptthemen laut MEDLINE: Referral and Consultation, Veterans, Liver Cirrhosis, Fatty Liver. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Global metabolic dysfunction-associated steatotic liver disease (MASLD) prevalence is estimated at 30% and projected to reach 55.7% by 2040. In the Veterans Affairs (VA) healthcare system, an estimated 1.8 million veterans have metabolic dysfunction-associated steatohepatitis (MASH).

Methods

Adult patients at risk for MASLD in a VA healthcare system underwent Fibrosis-4 (FIB-4) and Enhanced Liver Fibrosis (ELF®) testing. Referral rates and cost savings were compared among 6 noninvasive testing (NIT) strategies using these 2 tests independently or sequentially at various cutoffs.

Results

Enrolled patients (N = 254) had a mean age of 65.3 ± 9.3 years and mean body mass index (BMI) of 31.7 ± 6, 87.4% male: 78.3% were non-Hispanic/Latino, and 96.5% had type 2 diabetes mellitus (T2DM). Among the 6 evaluated strategies, using FIB-4 followed by ELF at a 9.8 cutoff yielded the highest proportion of patients retained in primary care without need of referral to hepatology clinic (165/227; 72.7%), and was associated with the lowest costs ($407.62). Compared to the FIB-4 only strategy, FIB-4/ELF with a 9.8 cutoff strategy resulted in 26% fewer referrals and 8.47% lower costs. In the subgroup of patients with BMI >32, there were 25.17% fewer referrals and costs were 8.31% lower.

Conclusions

Our study suggests that sequential use of ELF with a 9.8 cutoff following indeterminate FIB-4 tests results in lower referral rates and lower care costs in a veteran population at risk of MASLD. Adding ELF as a sequential test after indeterminate FIB-4 might help reduce the number of referrals and overall cost of care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Referral and ConsultationVeteransLiver CirrhosisFatty LiverHumansMaleFemaleAgedMiddle AgedUnited StatesLiver Function TestsUnited States Department of Veterans Affairs

Autor:innen und Institutionen

  • Medical Affairs, Siemens Healthcare Diagnostics Inc., Tarrytown, NY, United States.
  • Department of Radiology, Veterans Affairs Palo Alto Healthcare System, Palo Alto, CA, United States.
  • Department of Radiology, Stanford University Medical Center, Stanford, CA, United States.
  • Department of Gastroenterology and Hepatology, VA Palo Alto Healthcare System, Palo Alto, CA, United States.
  • Department of Gastroenterology and Hepatology, Stanford University Medical Center, Stanford, CA, United States.
  • Jefferson College of Population Health, Thomas Jefferson University, Philadelphia, PA, United States.

ORCID-Profile: Artem T Boltyenkov

Zitieren

APA

Yeramaneni, S., Chang, S. T., Cheung, R. C., Chalfin, D. B., Sangha, K., Levy, H. R., & Boltyenkov, A. T. (2025). Comparison of Referral Rates and Costs Using Fibrosis-4 and Enhanced Liver Fibrosis (ELF) Testing Strategies for Initial Evaluation of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in a Veteran Population. The Journal of Applied Laboratory Medicine, 10(3), 593-604. https://doi.org/10.1093/jalm/jfae154

Vancouver

Yeramaneni S, Chang ST, Cheung RC, Chalfin DB, Sangha K, Levy HR, et al. Comparison of Referral Rates and Costs Using Fibrosis-4 and Enhanced Liver Fibrosis (ELF) Testing Strategies for Initial Evaluation of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in a Veteran Population. The Journal of Applied Laboratory Medicine. 2025;10(3):593-604. doi:10.1093/jalm/jfae154

BibTeX
@article{Yeramaneni2025,
  author = {Yeramaneni, Samrat and Chang, Stephanie T and Cheung, Ramsey C and Chalfin, Donald B and Sangha, Kinpritma and Levy, H Roma and Boltyenkov, Artem T},
  title = {Comparison of Referral Rates and Costs Using Fibrosis-4 and Enhanced Liver Fibrosis (ELF) Testing Strategies for Initial Evaluation of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in a Veteran Population},
  journal = {The Journal of Applied Laboratory Medicine},
  year = {2025},
  volume = {10},
  number = {3},
  pages = {593--604},
  doi = {10.1093/jalm/jfae154}
}
Kostenlos starten →